Adjustment of Chemotherapy Duration in Follicular Lymphoma According to Minimal Residual Disease Status

NCT04934930 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Meir Medical Center

Collaborators